🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Secondary Pneumococcal Disease in Veterans with Viral Respiratory Infections ✅ Just Accepted 🔗 bit.ly/4dNBg8I

Blips: Important Observations, Cautious Conclusions?Accounting for Testing Frequency and Adherence ✅ Just Accepted 🔗 bit.ly/44aJrrt

Clinical and microbiological characteristics of meningococcal eye infections: retrospective national surveillance in England, 2010-2022. ✅ Just Accepted 🔗 bit.ly/4kTemzc

Premature Demise of the Milwaukee Protocol ✅ Just Accepted #IDTwitter 🔗 bit.ly/3T7W7Kj

A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis ✅ Just Accepted 🔗 bit.ly/4kPAEBJ

New Data and Next Steps for Clarifying how the Timing of Antiretroviral Therapy Initiation Influences Viral Blips and HIV Reservoir Size ✅ Just Accepted 🔗 bit.ly/4jFye7Z

Considerations about patients with Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors treatment in recurrent urinary tract infections. ✅ Just Accepted 🔗 bit.ly/43sWxRA

Stool processing methods for Xpert Ultra testing in childhood tuberculosis: A prospective, multi-country accuracy study ✅ Just Accepted 🔗 bit.ly/4jC4UPx

Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for RSV Disease Aged 18 to 59 Years ✅ Just Accepted 🔗 bit.ly/3FH1P2O

Pivmecillinam susceptibility in clinical practice: Contextualising findings from a systematic review ✅ Just Accepted 🔗 bit.ly/3T8fe6X

Incidence of AIDS-defining Conditions among Adults with Perinatally Acquired HIV after Transition to Adult HIV Care in the United States and Canada, 2000-2022 ✅ Just Accepted 🔗 doi.org/10.1093/cid/ci…

Non-Operative versus Neurosurgical Treatment of Brain Abscess: An Emulated Trial Nested within a Nationwide, Population-Based Cohort ✅ Just Accepted doi.org/10.1093/cid/ci…

Effectiveness and safety of Autologous Virus-Specific T Cell Therapy for Persistent COVID-19 in People with Immunocompromise: A Clinical Trial Study ✅ Just Accepted bit.ly/4kwMuks

Characteristics Associated with Disseminated Gonococcal Infections vs Uncomplicated Gonorrhea: A California Case-Control Study, 2021-2022 ✅ Just Accepted 🔗 bit.ly/43F59Vq

One Hundred Days, Incalculable Losses ✅ Just Accepted ⭐️ Editor's Choice 🔗 bit.ly/3ZwaUSS

Dr. Emily Erbelding reminds us: the future of infectious diseases research relies on our voices. Let’s make sure Congress understands what’s at stake. The IDSA Member Advocacy Program is a strong place to start ➡️ bit.ly/3Z44hHR

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab ✅ Just Accepted 🔗 bit.ly/4kvcPiy

A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis ✅ Just Accepted 🔗 bit.ly/4kPAEBJ

Association Between Delayed Broad-Spectrum Gram-negative Antibiotics and Clinical Outcomes: How Much Does Getting It Right With Empiric Antibiotics Matter? bit.ly/447fbh2

Executive Summary: State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis—Implications for Infectious Diseases Specialists 🔗 bit.ly/3G0VHT2